Yet Another Shake-Up for Valeant Pharmaceuticals

Mar 21, 2016, 11:03 PM

Headliner
Share
Subscribe

The Moneybeat crew catches up with the latest news out of Valeant Pharmaceuticals, as its board sees a huge shakeup amid waves of controversy and a plunging stock price.

Share
Subscribe
Next
Paul Nolte: Market Could Start to Struggle Again
Top episodes
How Printing Fake Money Helped People Manage Their Cash
by WSJ Your Money Matters
Where to Put Your Cash if the Fed Lowers Interest Rates
by WSJ Your Money Matters
How to Get Out of Debt
by WSJ Your Money Matters